Whole sample, excluding AD group (n = 91, number of observations = 364)
|
DMN-DAN (n = 91, number of observations = 364)
|
DMN-DAN × Aβ × (Time2)
|
0.42
|
0.16
|
0.10 to 0.74
|
266
|
2.60
|
0.01
|
0.02
|
DMN-SN (n = 91, number of observations = 364)
|
DMN-SN × Aβ × (Time2)
|
0.25
|
0.14
|
−0.02 to 0.52
|
266
|
1.84
|
0.07
|
0.07
|
Subset of participants with positive correlation between DMN and DANb
|
Whole sample, excluding AD group (n = 39, number of observations = 157)
|
Aβ × Time
|
−0.43
|
0.15
|
−0.73 to −0.13
|
116
|
−2.83
|
0.01
|
0.01
|
CN (n = 10, number of observations = 43)
|
Aβ × Time
|
0.22
|
0.20
|
−0.19 to 0.63
|
31
|
1.08
|
0.29
|
0.29
|
MCI (n = 29, number of observations = 114)
|
Aβ × Time
|
−0.44
|
0.13
|
−0.69 to −0.18
|
83
|
−3.43
|
0.001
|
0.001
|
Subset of participants with negative correlation between DMN and DANa
|
Whole sample. Excluding AD group (n = 52, number of observations = 207)
|
Aβ × (Time2)
|
−0.05
|
0.01
|
−0.07 to − 0.03
|
152
|
−4.23
|
< 0.001
|
< 0.001
|
CN (n = 18, number of observations = 75)
|
Aβ × (Time2)
|
−0.25
|
0.08
|
−0.41 to − 0.10
|
53
|
−3.33
|
0.001
|
0.001
|
MCI (n = 34, number of observations = 132)
|
Aβ × Time
|
− 0.26
|
0.15
|
− 0.56 to 0.04
|
96
|
−1.73
|
0.09
|
0.09
|